Integral Health Asset Management, LLC Historic Quarter Change: USA Options, Sold Out

Integral Health Asset Management, LLC historic quarter change: USA Options, Sold out

In put and call options, at their filed underlying value (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Integral Health Asset Management, LLC opened 21 positions, added to 3, reduced 3 and sold out of 21.

Q2 2026: Stock CYTK; Country of operation United States; Class COM NEW · Call; Shares before 1,000,000.
Q2 2026: Stock RVMD; Country of operation United States; Class COM · Call; Shares before 500,000.
Q2 2026: Stock MLYS; Country of operation United States; Class COM · Call; Shares before 500,000.
Q4 2025: Stock NAMS; Country of operation —; Class ORDINARY SHARES · Put; Shares before 1,000,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1773206), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.

Quarter	Stock	Country of operation	Class	Shares before	Share change	Value before	Value after	Value change	Filed
Q2 2026	CYTK CYTOKINETICS INC	United States	COM NEW · Call	1,000,000	-1,000,000	$65,910,000	$0	-$65,910,000	2026-08-14
Q2 2026	RVMD REVOLUTION MEDICINES INC	United States	COM · Call	500,000	-500,000	$48,625,000	$0	-$48,625,000	2026-08-14
Q2 2026	MLYS MINERALYS THERAPEUTICS INC	United States	COM · Call	500,000	-500,000	$13,545,000	$0	-$13,545,000	2026-08-14
Q4 2025	NAMS NEWAMSTERDAM PHARMA COMPANY		ORDINARY SHARES · Put	1,000,000	-1,000,000	$28,440,000	$0	-$28,440,000	2026-02-17
Q4 2025	INSM INSMED INC	United States	COM PAR $.01 · Put	100,000	-100,000	$14,401,000	$0	-$14,401,000	2026-02-17
Q3 2025	VKTX VIKING THERAPEUTICS INC	United States	COM · Call	200,000	-200,000	$5,300,000	$0	-$5,300,000	2025-11-14
Q2 2025	ACLX ARCELLX INC	United States	COMMON STOCK · Call	200,000	-200,000	$13,120,000	$0	-$13,120,000	2025-08-14
Q2 2025	XENE XENON PHARMACEUTICALS INC		COM · Put	200,000	-200,000	$6,710,000	$0	-$6,710,000	2025-08-14
Q2 2025	EWTX EDGEWISE THERAPEUTICS INC	United States	COM · Call	300,000	-300,000	$6,600,000	$0	-$6,600,000	2025-08-14
Q2 2025	RNAM AVIDITY BIOSCIENCES INC	United States	COM · Put	200,000	-200,000	$5,904,000	$0	-$5,904,000	2025-08-14
Q1 2025	INSM INSMED INC	United States	COM PAR $.01 · Call	500,000	-500,000	$34,520,000	$0	-$34,520,000	2025-05-15
Q4 2024	VKTX VIKING THERAPEUTICS INC	United States	COM · Call	250,000	-250,000	$15,827,500	$0	-$15,827,500	2025-02-14
Q4 2024	CLDX CELLDEX THERAPEUTICS INC NEW	United States	COM NEW · Call	300,000	-300,000	$10,197,000	$0	-$10,197,000	2025-02-14
Q3 2024	IONS IONIS PHARMACEUTICALS INC	United States	COM · Call	500,000	-500,000	$23,830,000	$0	-$23,830,000	2024-11-14
Q3 2024	TARS TARSUS PHARMACEUTICALS INC	United States	COM · Put	400,000	-400,000	$10,872,000	$0	-$10,872,000	2024-11-14
Q2 2024	VKTX VIKING THERAPEUTICS INC	United States	COM · Put	300,000	-300,000	$24,600,000	$0	-$24,600,000	2024-08-14
Q2 2024	INSM INSMED INC	United States	COM PAR $.01 · Call	500,000	-500,000	$13,565,000	$0	-$13,565,000	2024-08-14
Q2 2024	EXAS EXACT SCIENCES CORP	United States	COM · Call	150,000	-150,000	$10,359,000	$0	-$10,359,000	2024-08-14
Q2 2024	MLTX MOONLAKE IMMUNOTHERAPEUTICS	Switzerland	CLASS A ORD · Call	200,000	-200,000	$10,046,000	$0	-$10,046,000	2024-08-14
Q1 2024	CYTK CYTOKINETICS INC	United States	COM NEW · Call	400,000	-400,000	$33,396,000	$0	-$33,396,000	2024-05-15
Q1 2024	CYTK CYTOKINETICS INC	United States	COM NEW · Put	100,000	-100,000	$8,349,000	$0	-$8,349,000	2024-05-15

Similar Firms

Firm Name	Country	13F Value	Holdings
Klingman & Associates, LLC	United States	$2.089B	332
CSS LLC/IL	United States	$2.088B	961
Analog Century Management LP	United States	$2.094B	25
NEW SOUTH CAPITAL MANAGEMENT INC	United States	$2.087B	75
Aventail Capital Group, LP	United States	$2.086B	170
NLB Skladi, upravljanje premozenja, d.o.o.		$2.086B	335
Third Point LLC	United States	$2.083B	33
Avantyr Capital Partners, LP	United States	$2.082B	22
TruWealth Advisors, LLC	United States	$2.081B	182
Avala Global LP	United States	$2.081B	22